# 6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)

> **NCT00738738** · PHASE3 · WITHDRAWN · sponsor: **Pfizer**

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** PD-0332334

## Key facts

- **NCT ID:** NCT00738738
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-01
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Please see Detailed Description for termination reason.
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00738738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00738738, "6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00738738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*